LM
INSIDER · INBX · Inhibrx Biosciences, Inc. · CHIEF EXECUTIVE OFFICER
Lappe Mark
Every open-market transaction filed under this name, Sep 8 to Sep 8.
Filings
6
6 buys · 0 sells
Bought
$2.6M
open market, at cost
Sold
—
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 9,681 | $112.28 | $1.1M | — |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 1,219 | $111.88 | $136K | — |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 500 | $108.23 | $54K | — |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 1,100 | $107.12 | $118K | — |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 6,605 | $100.64 | $665K | — |
| Sep 8 | INBX | Inhibrx Biosciences, Inc. | Chief Executive Officer | Buy | 5,895 | $99.29 | $585K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.